Zhang Qing-Yi, Li He-Xi, Xie Hui-Qi, Liu Li-Min, Chen Li, Zeng Yi
Department of Orthopedic Surgery and Orthopedic Research Institute, Stem Cell and Tissue Engineering Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, People's Republic of China.
Analytical & Testing Center, Sichuan University, Chengdu, 610041, Sichuan, People's Republic of China.
Arch Orthop Trauma Surg. 2024 Dec 23;145(1):88. doi: 10.1007/s00402-024-05689-5.
The two-stage exchange revision represents a pivotal strategy in the management of prosthetic joint infections, wherein the judicious timing of reimplantation serves as a crucial determinant for therapeutic success. At present, attempts have been made to utilize predictive models to establish the optimal timing for reimplantation; however, their predictive accuracy remains unsatisfactory. This inadequacy primarily arises from the lack of dependable predictive indicators, which demonstrate inconsistent effectiveness across various studies and occasionally yield contradictory outcomes. Therefore, identifying solid predictive indicators is in desperate need.
Studies reporting outcomes of the two-stage exchange revision till June, 2023 were systematically retrieved, screened and subject to quality analysis. Basic characteristics of these studies were firstly summarized. Subsequently, factors of interest regarding clinical information, blood and body fluid test results, pathogen test results of the recurrent and recurrent-free cohorts were extracted and submitted to a fixed or random effects model. Meanwhile, evaluation of publication bias and sensitivity was performed.
After filtering, a total of 45 studies were finally involved. Pooled analysis suggested that the recurrent cohort exhibited elevated incidences of body mass index (BMI) > 30, smoking and alcohol habits, diabetes, sinus tract, positive culture, and G, polymicrobial and drug-resistant infections. Additionally, higher levels of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), synovial white blood cell (WBC) count, and polymorphonuclear percentage (PMN%) were observed in the recurrent cohort. On the other hand, the results of D-dimer and fibrinogen were ambiguous, and no difference regarding peripheral WBC count was observed. Forest plots suggested a low risk of publication bias. Besides, sensitivity analysis indicated good stability of the aforementioned indicators, except D-dimer and fibrinogen.
To sum up, BMI > 30, smoking and alcohol habits, diabetes, sinus tract, positive culture, and G-, polymicrobial and drug-resistant infections, CRP, ESR, synovial WBC and PMN% exhibited significant differences between recurrent and recurrent-free cohorts. Therefore, these indicators may be considered as potential predictive factors for the further development of a prognostic model that aids the determination of reimplantation timing. Nevertheless, the efficacy of these indicators remains to be further confirmed.
Prospero ID: CRD42022296568.
两阶段翻修术是人工关节感染管理中的关键策略,其中再植入的合理时机是治疗成功的关键决定因素。目前,已尝试利用预测模型来确定再植入的最佳时机;然而,其预测准确性仍不尽人意。这种不足主要源于缺乏可靠的预测指标,这些指标在不同研究中的有效性不一致,偶尔还会产生相互矛盾的结果。因此,迫切需要确定可靠的预测指标。
系统检索、筛选并对截至2023年6月报告两阶段翻修术结果的研究进行质量分析。首先总结这些研究的基本特征。随后,提取复发组和未复发组的临床信息、血液和体液检测结果、病原体检测结果等相关因素,并纳入固定或随机效应模型。同时,进行发表偏倚和敏感性评估。
筛选后,最终纳入45项研究。汇总分析表明,复发组体重指数(BMI)>30、吸烟和饮酒习惯、糖尿病、窦道、培养阳性以及革兰氏阴性菌、多微生物和耐药感染的发生率较高。此外,复发组的C反应蛋白(CRP)、红细胞沉降率(ESR)、滑膜白细胞(WBC)计数和多形核百分比(PMN%)水平较高。另一方面,D-二聚体和纤维蛋白原的结果不明确,外周血白细胞计数无差异。森林图显示发表偏倚风险较低。此外,敏感性分析表明,除D-二聚体和纤维蛋白原外,上述指标具有良好的稳定性。
综上所述,BMI>30、吸烟和饮酒习惯、糖尿病、窦道、培养阳性以及革兰氏阴性菌、多微生物和耐药感染、CRP、ESR、滑膜白细胞和PMN%在复发组和未复发组之间存在显著差异。因此,这些指标可被视为潜在的预测因素,有助于进一步开发辅助确定再植入时机的预后模型。然而,这些指标的有效性仍有待进一步证实。
Prospero ID:CRD42022296568。